Terapevticheskii Arkhiv

(The H4-Index of Terapevticheskii Arkhiv is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Novel coronavirus infection COVID-19: extrapulmonary manifestations23
Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases22
Evaluation of the effectiveness of Riamilovir in the complex therapy of patients with COVID-1920
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities20
Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuri15
Experience of olokizumab use in COVID-19 patients14
The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection14
Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)12
Rebamipide: evidence base for use in gastroenterology12
ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients wit11
The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation11
Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management11
Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity11